We discovered that the mTOR pathway was triggered by E. coli NF73-1 in mice with NAFLD, which is characterized by an increase in mTOR-mediated phosphorylation and activity of S6K1 and S6. This evidence concerns the gene RPS6 and metabolic dysfunction-associated steatotic liver disease.